Start the conversation
Comment on This Story
Or to contact Money Morning Customer Service, click here.
Equifax Inc. (NASDAQ: EFX) recently settled with the Federal Trade Commission over its massive 2017 consumer data breach, and it's big.
Just look at the sheer scope of it.
The credit reporting agency agreed to pay up to $700 million to settle claims brought by the FTC and most of the states' attorneys general in a breach that saw more than 147 million people's data exposed. Equifax was even compelled to set up a website that consumers could access to determine whether or not their data was included in the breach.
Those dollar figures have brought some significant media attention, with the majority of stories focusing on how affected consumers can make their choice and file their claim.
But here's the thing: With just $31 million of that $700 million settlement set aside for financial claims, it's at least theoretically possible individual consumers could collect as little as twenty cents ($0.20) each for their trouble.
But I think consumers should get some real, substantial compensation after all the hassles they've been through. In fact, my wife and I were affected ourselves, and for a time, it was a big pain in the neck.
So today, I'm going to set Money Morning Members up much better than Equifax and the FTC ever could...
I'm going to tell you all about a stock that should "compensate" you better and better with each year as the "cyber century" rolls on and the red-hot cybersecurity sector gets hotter...
About the Author
Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...
- He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
- He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
- As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.
This all means the entire world is constantly seeking Michael's insight.
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.
Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
And even with decades of experience, Michael believes there has never been a moment in time quite like this.
Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.
To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.
His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.